Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Ecancermedicalscience|January 21, 2017
Central nervous system metastasis secondary to colorectal cancer: a retrospective cohort study of 20 casesSebastián Mondaca, Valentina Hornig, Pablo Munoz-Schuffenegger, et al.
Ecancermedicalscience|November 29, 2018
Regorafenib adjusted dose for Chilean patients with chemoresistant metastatic colorectal cancer: a case seriesJosé Luis Leal, Juan Briones, María Elisa Herrera, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|July 10, 2025
Early-Onset Colorectal Cancer: From Genetic Discovery to Clinical InnovationAnita Turk, Sebastián Mondaca, Bruno Nervi, et al.
Archives of Dermatological Research|October 14, 2021
Differential expression of programmed cell death ligand 1 (PD-L1) and inflammatory cells in basal cell carcinoma subtypesMatias Gompertz-Mattar, Juan Perales, Aditi Sahu, et al.
Revista Medica De Chile|April 20, 2016
[Benefit of adjuvant 5-fluorouracil based chemotherapy for colon cancer: a retrospective cohort study]Sebastián Mondaca, Constanza Villalón, José Luis Leal, et al.
Revista Medica De Chile|October 31, 2023
[Liver transplantation for non-resectable colorectal liver metastases: A review]Daniel García, Patricia Rebolledo, Pablo Achurra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2019
Response to Anti-EGFR Therapy in Patients with BRAF non-V600-Mutant Metastatic Colorectal CancerRona Yaeger, Daisuke Kotani, Sebastián Mondaca, et al.
JCO Global Oncology|October 10, 2024
Clinical and Genomic Characterization of <i>ERBB2</i>-Altered Gallbladder Cancer: Exploring Differences Between an American and a Chilean CohortSebastián Mondaca, Henry Walch, Santiago Sepúlveda, et al.
Value in Health Regional Issues|February 22, 2023
Impact of Adjuvant FOLFOX on Quality of Life and Peripheral Neuropathy Incidence in Patients With Gastric Cancer: A Prospective Cohort StudySebastián Mondaca, Mauricio P Pinto, Juan Briones, et al.
Ecancermedicalscience|March 29, 2021
Pathological complete response to neoadjuvant chemotherapy, but not the addition of carboplatin, is associated with improved survival in Chilean triple negative breast cancer patients: a report of real world dataBenjamín Walbaum, Francisco Acevedo, Lidia Medina, et al.
Pageof 2